Frontlight ResearchEarly access
Taking peopleNo phase
Toric Intraocular Lens (IOL) Implantation for Management of Cataracts
Key facts
- Who runs it
- Eye & ENT Hospital of Fudan University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 3,000 people, planned
- Started
- 1 Jun 2019
- Expected to end
- 31 May 2030
- Type of study
- Observational
- Record updated
- 19 June 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Cataract
Who cannot take part
- • small pupil; zonular dehiscence; preexisting corneal pathology; glaucoma; uveitis; a history of ocular trauma or surgery; severe intraoperative and postoperative complications
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study included cataract patients who underwent toric intraocular lens (IOL) implantation, which aimed to evaluate the stability and clinical visual quality of toric IOLs.
The group in the trial
- cataract patients implanted with toric IOLs
Cataract patients who received the implantation of different toric IOLs with different haptic designs
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Plate-haptic Toric Intraocular Lens (IOL) Implantation for Management of Cataracts
- Record updated
- 19 June 2025